Log in to save to my catalogue

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and system...

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and system...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_26131979

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma : CANCER TECHNOLOGIES

About this item

Full title

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma : CANCER TECHNOLOGIES

Publisher

New York, NY: Nature Publishing Group

Journal title

Nature biotechnology, 2012, Vol.30 (7), p.631-637

Language

English

Formats

Publication information

Publisher

New York, NY: Nature Publishing Group

More information

Alternative Titles

Full title

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma : CANCER TECHNOLOGIES

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pascalfrancis_primary_26131979

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_26131979

Other Identifiers

ISSN

1087-0156

E-ISSN

1546-1696

How to access this item